DUSTIN THOMPSON: Open Payments
NPI 1609452960 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,390 in 90 payments from 23 companies in 2025. Trend: 2023 $544 · 2024 $1,639 · 2025 $3,390
Food & beverage: $1,874Travel & lodging: $1,516
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,885 |
| Xeris Pharmaceuticals, Inc. | 10 | $200 |
| Corcept Therapeutics | 10 | $199 |
| SANOFI-AVENTIS U.S. LLC | 14 | $156 |
| Novartis Pharmaceuticals Corporation | 7 | $140 |
| Insulet Corporation | 1 | $135 |
| Lilly USA, LLC | 5 | $82 |
| BETA BIONICS, INC. | 4 | $81 |
| Amgen Inc. | 3 | $81 |
| Ascendis Pharma Endocrinology Inc | 4 | $70 |
Products named: MINIMED 780G, Korlym, LEQVIO, Omnipod, TZIELD, RECORLEV, MOUNJARO, iLet Bionic Pancreas.
Industry payments across UT — which companies pay providers there.
